Company Profile
Sartorius Stedim Biotech provides the production and sale of instruments and consumables for the biopharmaceutical industry globally. The company offers various products, such as cell lines.
Its portfolio also includes cell culture media, bioreactors, reagents, advanced therapies, and a range of products for separation, purification, and concentration processes products and systems for storage and transportation of intermediate and finished biological products, as well as fluid management services.
Its portfolio also includes biolayer interferometry instruments, microbiology testing, sterility testing, and air monitoring instruments, pipette products, sensors and analyzers, screening instruments, biomolecule analysis tools, batch liquid chromatography systems, lab data and fleet management software, live cell imaging and analysis, surface plasmon resonance solutions, water purification systems, and weighing products.
Additionally, it offers data analytics software. Its portfolio also includes process automation platform and software, and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions.
The company serves manufacturers of medications, vaccines, food, and chemicals, as well as R&D laboratories. Incorporated in 1978, the company is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.